Ju Ying-Tzu, Wei Yu-Jen, Lin Yung-Chieh, Hsieh Min-Ling, Wu Jing-Ming, Wang Jieh-Neng
Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng-Kung University, Tainan 704302, Taiwan.
Institute of Clinical Medicine, College of Medicine, National Cheng-Kung University, Tainan 701401, Taiwan.
Children (Basel). 2021 Nov 5;8(11):1017. doi: 10.3390/children8111017.
Cardiovascular catheterization has been applied in infant treatment for several decades. To date, considerable research attention has been paid to cardiovascular catheterization in small neonates. However, peripheral vascular routes of catheterization are possible obstacles for interventionists. Umbilical vein catheterization has been reported as a route for neonates, although few attempts have been made to investigate this approach. This study aimed to retrospectively review cardiovascular intervention using the umbilical vein approach as applied to infants admitted to a tertiary center from 2017 to 2020. Details including the perinatal variables, indication diagnoses, and procedure devices were collected. The enrollment included a total of 16 cases representing 17 intervention events, with infants born at a gestation age of 22-39 weeks and body weight ranging from 478 to 3685 g at the time of the procedure. The postnatal age ranged from 1 to 27 days. The catheter sizes ranged from 4 to 11 Fr. Indications included being admitted for patent ductus arteriosus occlusion ( = 15), balloon pulmonary valvuloplasty ( = 3), balloon atrial septostomy (BAS) ( = 3), pulmonary valve (PV) perforation ( = 1), and two interventions for catheter placement for continuous venovenous hemofiltration. The success rate for cardiovascular catheterization was 88.2% (15/17). There were two patients for which cannulation failed due to ductus venosus closure: one intraabdominal hemorrhage complication during continuous venovenous hemofiltration (CVVH), and one cardiac catheterization failure of PV perforation due to failure to insert the guiding catheter into the right ventricular outflow tract. Based on these findings, we conclude that cardiac catheterization and the placement of a large-sized catheter through an umbilical vein in a small infant represents a safe and time-saving method when catheterization is required.
心血管导管插入术已应用于婴儿治疗数十年。迄今为止,小型新生儿的心血管导管插入术已受到相当多的研究关注。然而,外周血管导管插入途径可能是介入医生面临的障碍。脐静脉导管插入术已被报道为新生儿的一种途径,尽管很少有人尝试研究这种方法。本研究旨在回顾性分析2017年至2020年在一家三级中心住院的婴儿采用脐静脉途径进行心血管介入治疗的情况。收集围产期变量、适应症诊断和手术器械等详细信息。纳入的病例共有16例,代表17次介入事件,婴儿出生时的孕周为22 - 39周,手术时体重在478至3685克之间。出生后年龄在1至27天之间。导管尺寸范围为4至11 Fr。适应症包括动脉导管未闭封堵(n = 15)、球囊肺动脉瓣成形术(n = 3)、球囊房间隔造口术(BAS)(n = 3)、肺动脉瓣(PV)穿孔(n = 1)以及两次用于持续静脉 - 静脉血液滤过的导管置入干预。心血管导管插入术的成功率为88.2%(15/17)。有两名患者因静脉导管闭合导致插管失败:一名在持续静脉 - 静脉血液滤过(CVVH)期间出现腹腔内出血并发症,一名因未能将引导导管插入右心室流出道导致PV穿孔心脏导管插入术失败。基于这些发现,我们得出结论,对于需要进行导管插入术的小婴儿,经脐静脉进行心脏导管插入术和置入大尺寸导管是一种安全且节省时间的方法。